A new class of cancer treatments called CAR-T cell therapies will require updates to their safety information to indicate a severe risk of secondary malignancies, according to the U.S. Food and Drug ...
Source LinkA new class of cancer treatments called CAR-T cell therapies will require updates to their safety information to indicate a severe risk of secondary malignancies, according to the U.S. Food and Drug ...
Source Link
Comments